Loading clinical trials...

The Role of Optic Nerve Sheath Fenestration in Leukemic Patients Having Increased Intracranial Pressure | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNPhase 2/3NCT04431882

The Role of Optic Nerve Sheath Fenestration in Leukemic Patients Having Increased Intracranial Pressure

Optic nerve sheath fenestration (ONSF) first described by De Wecker in 1872 for the treatment of neuroretinitis. Since then, optic nerve sheath fenestration has become well established procedure for t...

Lead sponsor: Alexandria University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusUNKNOWN

PhasePHASE2/PHASE3

Enrollment20

Start dateJun 2019

Last updatedJun 16, 2020

Condition

Leukemic Patients With Increased Intracranial Pressure Optic Nerve Sheath Fenestration

Locations shown

Alexandria Faculty of Medicine

Alexandria

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 16, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions